Bioinstrumentation Sector Poised to Grow 15% in 2001 | GenomeWeb

NEW YORK, Jan 22 – The bioinstrumentation sector is forecast to grow 15 percent this year to $4.3 billion, Strategic Directions International, a market research and consulting firm that tracks the instrument industry, said in a recent edition of its Instrument Business Outlook report.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.